AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baldanti, F.
Right arrow Articles by Gerna, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baldanti, F.
Right arrow Articles by Gerna, G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 1998, p. 444-446, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

The Cys607right-arrow Tyr Change in the UL97 Phosphotransferase Confers Ganciclovir Resistance to Two Human Cytomegalovirus Strains Recovered from Two Immunocompromised Patients

Fausto Baldanti,1 Mark R. Underwood,2 Christine L. Talarico,2 Lavinia Simoncini,1 Antonella Sarasini,1 Karen K. Biron,2 and Giuseppe Gerna1,*

Servizio di Virologia, IRCCS Policlinico S. Matteo, 27100 Pavia, Italy,1 and Department of Virology, Glaxo Wellcome Inc., Research Triangle Park, North Carolina 277092

Received 6 June 1997/Returned for modification 2 October 1997/Accepted 5 November 1997

Two ganciclovir (GCV)-resistant human cytomegalovirus (HCMV) strains recovered from an AIDS patient (strain VR4990) and a heart transplant recipient (strain VR5474) showed a Cys607right-arrowTyr change in the UL97-encoded phosphotransferase. No amino acid substitutions were observed in the viral DNA polymerase. Marker transfer experiments showed marked reduction in GCV phosphorylation and drug susceptibility of the recombinant HCMV strain VR4990rec2-1-1. These results further extend the region of the carboxy-terminal domain of the UL97 phosphotransferase involved in GCV substrate recognition.

* Corresponding author. Mailing address: Servizio di Virologia, IRCCS Policlinico S. Matteo, 27100 Pavia, Italy. Phone: 39-382-502644. Fax: 39-382-502599 and 39-382-423320. E-mail: virology{at}ipv36.unipv.it.

Antimicrobial Agents and Chemotherapy, February 1998, p. 444-446, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1998 by the American Society for Microbiology. All rights reserved.